Home | European Pharmaceutical Review

Featured content

Gaelic Labs: Pharma is increasingly focused on supply chain security

2026-04-01T08:30:00+01:00By Dominic Tyer (European Pharmaceutical Review)

General Manager Brian Morrissey discuss his company’s acquisition of fellow Beta-Lactam manufacturer Athlone Laboratories and its implications for an evolving industry.

Harnessing AI for more efficient clinical trials
2026-03-26T15:00:002026-03-26T16:00:00Sponsored by Medable
During this virtual panel, industry experts discussed practical examples and considerations for applying AI in pharma’s clinical trials.
Practical considerations for aseptic gowning in contamination control strategies
2026-02-25T15:00:00Sponsored by Particle Measuring Systems
Watch this webinar as we examine the main personnel-related factors that could lead to particle/microbial contamination risks of the product and outline practical measures that can mitigate these risks.
Complying with USP Chapters 41 and 1251 revisions for pharma quality control
2026-03-04T15:00:002026-03-04T16:00:00Sponsored by METTLER TOLEDO
Join this webinar to gain insight about the changes to United States Pharmacopeia (USP) General Chapters 41 and 1251 on balance requirements for quality control.
Navigating evolving clinical and regulatory expectations as mRNA outgrows its vaccine roots
2025-09-26T13:55:00+01:00By Jianbo Diao (WuXi AppTec)
Jianbo Diao, PhD, Director of Bioanalytical Services, WuXi AppTec, discusses the importance for mRNA therapy developers of adopting precise and flexible analytical strategies for future pipeline success.